N

Novartis Japan

11 employees

Novartis Pharma is the Japanese subsidiary of Novartis Pharmaceuticals, a world-leading healthcare company based in Basel, Switzerland

Investor insights

Sectors invested in

Biotechnology6
Health Care5
Therapeutics4
SaaS3
Medical Device2
allogeneic therapy2
chain of indentity2
track and trace2
Software2
automate2
data analytics2
Enterprise Software2
pharm software2
Cloud Computing2
chain of custody2
cell and gene therapy supply chain2
commercial phase2
clinical phase2
autologous therapy2
enterprise software2

Funding rounds participated in

$33M sweet spot round size

Most of their 7 investments are in rounds between $16M and $35M

Investor type

Venture Capital

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Pharmaceutical

Date founded

1997

Investments made

A

Alto Neuroscience raised $35M on October 25, 2022

Investors: Valor Equity Partners, infinitas capital, Vine Ventures, L.P., Presight Capital, Windham Venture Partners, Korify Capital AG, The Sobrato Organization and Novartis Japan

H

H1 raised $23M on June 9, 2022

Investors: Goldman Sachs Asset Management, Menlo Ventures, Leerink Transformation Partners and Novartis Japan

S

SomaLogic raised $375M on September 1, 2021

Investors: Casdin Capital, LLC, T. Rowe Price, Corvex Connected Worker™, Perceptive Advisors, Farallon Capital Management and Novartis Japan

D

Dopavision raised $14M on July 14, 2021

Investors: Ababax.Health, dRx data and Novartis Japan

V

Vineti raised $33M on October 13, 2020

Investors: Casdin Capital, LLC, Section 32, Lifeforce Capital, Canaan, Threshold Ventures and Novartis Japan

K

Koneksa raised $16M on September 28, 2020

Investors: dRx data, Spring Mountain Capital, MBX Capital, Waterline Ventures and Novartis Japan

V

Vineti raised $35M on February 5, 2020

Investors: Threshold Ventures, Casdin Capital, LLC, Section 32, -, Lifeforce Capital, Gilead Sciences, dRx data and Novartis Japan

FAQ